Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cognitive Effects of Chemotherapy and Cancer-Related Treatments in Older Adults
Jennifer N. Vega, Julie A. Dumas, Paul Newhouse
American Journal of Geriatric Psychiatry (2017) Vol. 25, Iss. 12, pp. 1415-1426
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021
Efrat Dotan, Louise C. Walter, Ilene Browner, et al.
Journal of the National Comprehensive Cancer Network (2021) Vol. 19, Iss. 9, pp. 1006-1019
Open Access | Times Cited: 128
Chemotherapy: how to reduce its adverse effects while maintaining the potency?
Brianna Brianna, Sau Har Lee
Medical Oncology (2023) Vol. 40, Iss. 3
Closed Access | Times Cited: 81
Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study
Jeanne S. Mandelblatt, Brent J. Small, George Luta, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 32, pp. 3211-3222
Open Access | Times Cited: 153
Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia
Kerry A. Rogers, Ying Huang, Amy S. Ruppert, et al.
Journal of Clinical Oncology (2020) Vol. 38, Iss. 31, pp. 3626-3637
Open Access | Times Cited: 91
How family caregivers of persons with advanced cancer assist with upstream healthcare decision-making: A qualitative study
J. Nicholas Dionne‐Odom, Deborah Ejem, Rachel Wells, et al.
PLoS ONE (2019) Vol. 14, Iss. 3, pp. e0212967-e0212967
Open Access | Times Cited: 83
Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach?
Sanne B. Schagen, Andrey S. Tsvetkov, Annette Compter, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 3, pp. 173-185
Closed Access | Times Cited: 65
Nose-to-brain delivery of chrysin transfersomal and composite vesicles in doxorubicin-induced cognitive impairment in rats: Insights on formulation, oxidative stress and TLR4/NF-kB/NLRP3 pathways
Shaimaa S. Ibrahim, Omar G. Abo Elseoud, Mohamed H. Mohamedy, et al.
Neuropharmacology (2021) Vol. 197, pp. 108738-108738
Closed Access | Times Cited: 58
Postoperative neurocognitive disorders
Cynthia Olotu
Current Opinion in Anaesthesiology (2019) Vol. 33, Iss. 1, pp. 101-108
Closed Access | Times Cited: 64
Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy
Noemí Cerulla, J. Blas Navarro, Núria de la Osa
Journal of Cancer Survivorship (2020) Vol. 14, Iss. 4, pp. 464-482
Closed Access | Times Cited: 54
Randomized Controlled Trial of Virtually Delivered Cognitive Behavioral Therapy for Insomnia to Address Perceived Cancer-Related Cognitive Impairment in Cancer Survivors
Sheila N. Garland, Joshua Tulk, Josée Savard, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 17, pp. 2094-2104
Closed Access | Times Cited: 6
Utilizing Melatonin to Alleviate Side Effects of Chemotherapy: A Potentially Good Partner for Treating Cancer with Ageing
Zhiqiang Ma, Liqun Xu, Dong Liu, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-20
Open Access | Times Cited: 47
International trends in cancer incidence in middle-aged and older adults in 44 countries
Sophie Pilleron, Naser Alqurini, Jacques Ferlay, et al.
Journal of Geriatric Oncology (2021) Vol. 13, Iss. 3, pp. 346-355
Closed Access | Times Cited: 37
Elevated C-Reactive Protein and Subsequent Patient-Reported Cognitive Problems in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study
Judith Carroll, Zev M. Nakamura, Brent J. Small, et al.
Journal of Clinical Oncology (2022) Vol. 41, Iss. 2, pp. 295-306
Open Access | Times Cited: 25
Neurological Complications of Conventional and Novel Anticancer Treatments
Paola Alberti, Alessandro Salvalaggio, Andreas A. Argyriou, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6088-6088
Open Access | Times Cited: 21
Prevalence and associated factors of chemotherapy‐related cognitive impairment in older breast cancer survivors
Xuan Zhou, Xueyan Zhang, Tangsheng Zhong, et al.
Journal of Advanced Nursing (2023) Vol. 80, Iss. 2, pp. 484-499
Closed Access | Times Cited: 12
Potential of Natural Phenolic Compounds against Doxorubicin-Induced Chemobrain: Biological and Molecular Mechanisms Involved
Simona Serini, Gabriella Calviello
Antioxidants (2024) Vol. 13, Iss. 4, pp. 486-486
Open Access | Times Cited: 4
A nomogram for predicting cancer-related cognitive impairment in lung cancer patients from a nursing science precision health model perspective
Lei Ye, Xiaoyu Xu, Lijuan Liu, et al.
Supportive Care in Cancer (2025) Vol. 33, Iss. 4
Closed Access
Self-Reported Cognitive Function in Older Breast Cancer Survivors after Chemotherapy Treatment
Rachel Kim, Julia Peña, Kaiping Liao, et al.
The Breast (2025) Vol. 81, pp. 104468-104468
Open Access
Molecular Subtypes and Targeted Therapeutic Strategies in Small Cell Lung Cancer: Advances, Challenges, and Future Perspectives
Daoyuan Huang, Jingchao Wang, Li Chen, et al.
Molecules (2025) Vol. 30, Iss. 8, pp. 1731-1731
Open Access
The Role of Family Caregivers in the Care of Older Adults with Cancer
Virginia Sun, Martine Puts, Kristen R. Haase, et al.
Seminars in Oncology Nursing (2021) Vol. 37, Iss. 6, pp. 151232-151232
Closed Access | Times Cited: 20
Enzyme-Activated Multifunctional Prodrug Combining Site-Specific Chemotherapy with Light-Triggered Photodynamic Therapy
Hongxia Zhang, Hao-Hua Lin, Dan Su, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 2, pp. 630-641
Closed Access | Times Cited: 13
An update on breast cancer chemotherapy-associated toxicity and their management approaches
Urvashi Langeh, Vishal Kumar, Palak Ahuja, et al.
Health Sciences Review (2023) Vol. 9, pp. 100119-100119
Open Access | Times Cited: 7
Brain white matter microstructural changes in chemotherapy‐treated older long‐term breast cancer survivors
E Furst Daniel, Frank Deng, Sunita K. Patel, et al.
Cancer Medicine (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Chronic Lymphocytic Leukemia: Management of Adverse Events in the Era of Targeted Agents
Andrea Galitzia, Monica Maccaferri, Francesca Romana Mauro, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 1996-1996
Open Access | Times Cited: 2
A selective CuII complex with 4-fluorophenoxyacetic acid hydrazide and phenanthroline displays DNA-cleaving and pro-apoptotic properties in cancer cells
Pedro Henrique Alves Machado, Drielly A. Paixão, Ricardo Campos Lino, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top